Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06106308 |
|---|---|
| Brief Title: | Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation |
| First Submitted : | October 24, 2023 |
| First Submitted that Met QC Criteria : | October 24, 2023 |
| First Posted : | October 30, 2023 |
| Last Update Submitted that Met QC Criteria : | May 2, 2024 |
| Last Update Posted : | May 3, 2024 |